IP Library Granted Patent US 8,450,390
Granted Patent B2
US 8,450,390 · App. 13/554,292 · Granted May 28, 2013

Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,450,390
App. No.
13/554,292
Granted
May 28, 2013
Kind
B2
Abstract

The present invention provides both crosslinked polymer compositions capable of forming hydrogels upon exposure to an aqueous environment and thiosulfonate hydrogel-forming components. The thiosulfonate hydrogel-forming components of the invention are preferably multi-arm thiosulfonate polymer derivatives that form a crosslinked polymer composition when exposed to a base without requiring the presence of a second cross-linking reagent, redox catalyst, or radiation. Methods for forming hydrogel compositions, as well as methods for using the hydrogels, are also provided.

Claims (29)

1. A hydrogel composition comprising comprising an active agent and crosslinked thiosulfonate derivatives, wherein each thiosulfonate derivative, prior to being crosslinked, has the formula:

wherein:

POLY is a water-soluble polymer;

(n) is 3 to about 25;

X is a linking group;

Y is moiety derived from a molecule having at least three nucleophilic groups, and R is an organic radical;

POLY' is water-soluble polymer (either the same or different than POLY);

Z is a functional group having low reactivity with thiosulfonate, sulfhydryl, and disfulde linkages; and

(m) is a positive integer.

2. The hydrogel composition of claim 1 , wherein both POLY and POLY' are the water-soluble poly(ethylene glycol)s.

3. The hydrogel composition of claim 1 , wherein (n) is 3 to 10.

4. The hydrogel composition of claim 3 , wherein (n) is 3.

5. The hydrogel composition of claim 3 , wherein (n) is 4.

6. The hydrogel composition of claim 3 , wherein (n) is 5.

7. The hydrogel composition of claim 6 , wherein (n) is 6.

8. The hydrogel composition of claim 1 , wherein the organic radical is alkyl or aryl.

9. The hydrogel composition of claim 1 , wherein the organic radical is methyl.

10. The hydrogel composition of claim 1 , wherein the organic radical is phenyl.

11. The hydrogel composition of claim 2 , wherein each of the poly(ethylene glycol)s has a molecular weight of from 200 Da to about 20,000 Daltons.

12. The hydrogel composition of claim 11 , wherein each of the poly(ethylene glycol)s has a molecular weight of from 500 Da to about 15,000 Daltons.

13. The hydrogel composition of claim 11 , wherein each of the poly(ethylene glycol)s has a molecular weight of from 600 Da to about 6,000 Daltons.

14. The hydrogel composition of claim 1 , wherein the molecule having at least three nucleophilic groups is selected from the group consisting of glycerol, oligoglycerols, pentaerythritol, carbohydrates, and cyclodextrin.

15. The hydrogel composition of claim 1 , wherein the molecule having at least three nucleophilic groups is glycerol.

16. The hydrogel composition of claim 1 , wherein the molecule having at least three nucleophilic groups is an oligoglycerol.

17. The hydrogel composition of claim 1 , wherein the molecule having at least three nucleophilic groups is

18. The hydrogel composition of claim 1 , wherein the molecule having at least three nucleophilic groups is pentaerythritol.

19. The hydrogel composition of claim 1 , wherein the molecule having at least three nucleophilic groups is 1,2,3-propane-triamine.

20. The hydrogel composition of claim 1 , wherein (m), is selected from the group consisting of 1, 2, 3, 5 and 10.

21. The hydrogel composition of claim 1 , wherein the active agent is a non-steroidal anti-inflammatory drug.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 30040, FRAME 0952 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036855/0793 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
SECURITY AGREEMENT Recorded Mar 19, 2013
From: NEKTAR THERAPEUTICS
To: WELLS FARGO, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030040/0952 →